Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04960514 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04960514 · ClinicalTrials.gov record · last posted 2026-08-13

Prospective Decision Impact Trial of KidneyIntelX

StatusActive, Not Recruiting
PhaseNot specified
Started2021-11-22
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The current trial is designed to evaluate how the results of KidneyIntelX test / platform impacts on the clinical management of type 2 diabetes patients identified as increased risk for rapid kidney function decline within 5-years.

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2021-07-02; most recent amendment 2024-04-11. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-04-11
Status change Recruiting→Active, Not Recruitingv3
2021-11-22
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT04960514
Lead Sponsor Renalytix AI, Inc.
Conditions Diabetic Kidney Disease, Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2, Chronic Kidney Disease, Stage 3 (Moderate)
Enrollment 2,000 participants
Start Date 2021-11-22
Primary Completion 2023-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13